Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Meiler

Showing results (411-420 of 432) with videos related to

Pageof 44
Sort By:
JCI Insight|August 26, 2025
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancerAmanda B Hesterberg, Hong Yuen Wong, Jorgen Jackson, et al.
Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Plos Computational Biology|May 5, 2020
Better together: Elements of successful scientific software development in a distributed collaborative communityJulia Koehler Leman, Brian D Weitzner, P Douglas Renfrew, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Immunity|December 23, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signalingJayakumar Manoharan, Rajiv Rana, Georg Kuenze, et al.
Biochemistry|March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen DesignClara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Molecular Genetics & Genomic Medicine|December 17, 2025
Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural AnalysesYutaka Furuta, Kimberly M Ezell, Rizwan Hamid, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Methods in Enzymology|December 29, 2010
ROSETTA3: an object-oriented software suite for the simulation and design of macromoleculesAndrew Leaver-Fay, Michael Tyka, Steven M Lewis, et al.
Cancer Letters|May 23, 2026
EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecanSarah J Harmych, Neeraj Joshi, Hidenori Tanaka, et al.
Pageof 44

Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
JCI Insight|August 26, 2025
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancerAmanda B Hesterberg, Hong Yuen Wong, Jorgen Jackson, et al.
Cancer Discovery|April 23, 2016
EGFR Fusions as Novel Therapeutic Targets in Lung CancerKartik Konduri, Jean-Nicolas Gallant, Young Kwang Chae, et al.
Plos Computational Biology|May 5, 2020
Better together: Elements of successful scientific software development in a distributed collaborative communityJulia Koehler Leman, Brian D Weitzner, P Douglas Renfrew, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Immunity|December 23, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signalingJayakumar Manoharan, Rajiv Rana, Georg Kuenze, et al.
Biochemistry|March 11, 2021
Modeling Immunity with Rosetta: Methods for Antibody and Antigen DesignClara T Schoeder, Samuel Schmitz, Jared Adolf-Bryfogle, et al.
Molecular Genetics & Genomic Medicine|December 17, 2025
Phenotypic Variability and Paternal Inheritance of a CHD8 Variant Causing Intellectual Developmental Disorder With Autism and Macrocephaly Confirmed by Epigenetic and Structural AnalysesYutaka Furuta, Kimberly M Ezell, Rizwan Hamid, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Methods in Enzymology|December 29, 2010
ROSETTA3: an object-oriented software suite for the simulation and design of macromoleculesAndrew Leaver-Fay, Michael Tyka, Steven M Lewis, et al.
Cancer Letters|May 23, 2026
EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecanSarah J Harmych, Neeraj Joshi, Hidenori Tanaka, et al.
Pageof 44